ClinicalTrials.Veeva

Menu

Healthy Control Population for PAIS-ME/CFS: Study to Evaluate Possible Biomarkers and Methods for Examination of PAIS-ME/CFS Diagnostics in Healthy Volunteers (HelP)

T

Technical University of Munich

Status

Not yet enrolling

Conditions

Healthy Controls

Treatments

Diagnostic Test: Diagnostic Test

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Using the data from the HelP study, the underlying processes of the diseases ME/CFS and PAIS are to be researched and elucidated. The comparison of affected patients with healthy controls is intended to identify disease-specific patterns that could be related to the development or progression of the disease. The aim is to find a suitable biomarker for diagnostics and to develop therapeutic approaches.

Full description

The underlying pathomechanisms of the diseases PAIS and ME/CFS are to be investigated and elucidated in more detail. The aim is to establish a cohort of healthy controls at our MRI Chronic Fatigue Center (MCFC). Within this cohort, the measurement instruments used so far in ME/CFS diagnostics will be validated. In addition, data material from this pool should be used for the statistical evaluations of various case-control studies of our center and our cooperation partners in order to find and develop a suitable biomarker for diagnostics and therapeutic approaches for PAIS and ME/CFS.

Enrollment

200 estimated patients

Sex

All

Ages

10 to 25 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Healthy control subjects without a known medical diagnosis, except: asthma, allergies, neurodermatitis, if this does not require regular medication (self-disclosure)
  • Age: 10 - 25 years
  • Written declaration of consent or, in the case of minors, written declaration of consent from the participants and their legal representatives

Exclusion criteria

  • Acute illnesses (e.g. infections) or major injuries
  • Known chronic diseases (including psychological diagnoses) other than those mentioned above
  • Surgery or blood transfusion in the last 3 months
  • No intake of on-demand medication (e.g. painkillers) in the last 7 days before the date of the examination
  • Pregnancy; Breastfeeding
  • Limited legal capacity

Trial design

200 participants in 1 patient group

Healthy controls
Description:
Healthy participants between 10 and 25 years of age. We plan to recruit 5 to 10 participants per age group.
Treatment:
Diagnostic Test: Diagnostic Test

Trial contacts and locations

0

Loading...

Central trial contact

Prof. Dr. med. Uta Behrends

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems